Changes in Vascular Vasopressin Receptors and Responsiveness in DOCA/NACL-Treated Rats

References

• Hofbauer K. G., Mah S. C., Baum H. P., Hanni H., Wood J. M., Kraetz J. Endocrine control of salt and water excretion: the role of vasopressin in DOCA/NaCl hypertension. J. Cardiovasc. Pharmacol. 1984; 6: S184–191
   PubMed Web of Science ®Google Scholar
• Smith M. J., Cowley A. W., Guyton A. C., Manning R. D. Acute and chronic effects of vasopressin on blood pressure, electrolytes and fluid volumes. Amer. J. Physiol. 1979; 237: F232–F240
   PubMed Web of Science ®Google Scholar
• Schmid P. G., Scharabi F. M., Guo G. B., Abboud F. M., Thames M. D. Vasopressin and oxytocin in the neural control of the ciruclation. Fed. Proc. 1984; 43: 97–102
   PubMedGoogle Scholar
• Berecek K. H., Barron K. W., Webb R. L., Brody M. J. Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension 1982; 4(suppl. II)II–131–II–137
   Google Scholar
• Lais L. T., Shaffere R. A., Brody M. J. Neurogenic and humoral factors controlling vascular resistance in the spontaneously hypertensive rats. Circ. Res. 1974; 35: 764–774
   PubMed Web of Science ®Google Scholar
• Crofton J. T., Share L., Wang B. C., Shade R. E. Pressor responsiveness to vasopressin in the rat with DOCA-hypertension. Hypertension 1980; 2: 424–429
   PubMed Web of Science ®Google Scholar
• Berecek K. H., Stocker M., Gross F. Changes in renal vascular reactivity at various stages of deoxycorticosterone hypertension in rats. Circ. Res. 1980; 46: 619–624
   PubMed Web of Science ®Google Scholar
• Cowley A. W., Merril D., Osborn J., Barber B. J. Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ. Res. 1984; 54: 163–172
   PubMed Web of Science ®Google Scholar
• Berecek K. H., Murray R. D., Gross F., Brody M. J. Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension 1982; 4: 3–12
   PubMed Web of Science ®Google Scholar
• Crofton J. T., Share L., Shade R. E., Lee Kwon W. J., Manning M., Sawyer W. The importance of vasopressin in the development of DOC-salt hypertension in the rat. Hypertension 1979; 1: 31–38
   PubMed Web of Science ®Google Scholar
• Saito T., Yajima Y. Development of DOCA-NaCl hypertension in the Brattleboro rat. Ann. NY Acad. Sci. 1982; 394: 309–317
   PubMed Web of Science ®Google Scholar
• Mohring J., Mohring B., Perti M., Haack D. Vasopressor role of ADH in the pathogenesis of malignant DOCA hypertension. Amer. J. Physiol. 1977; 232: F260–F269
   PubMed Web of Science ®Google Scholar
• Altura M. M., Altura B. T. Vascular smooth muscle and neurohypophyseal hormones. Fed. Proc. 1977; 36: 1853–1967
   PubMedGoogle Scholar
• Haack D., Mohring J., Mohring B., Petri M., Hackenthal E. Comparative study on the development of corticosterone and DOCA hypertension inrats. Amer. J. Physiol. 1977; 233: F403–F411
   PubMed Web of Science ®Google Scholar
• Shimizu K., Share L., Claybaugh J. R. Potentiation by angiotension II of the vasopressin response to an increasing plasma osmolality. Endocrinolgoy 1973; 93: 42–50
   PubMed Web of Science ®Google Scholar
• Mohring B., Mohring J. Plasma ADH in normal Long-Evans rats and in Long-Evans rats heterozygous and homozygous for hypothalamic diabetes insipidus. Life Sci. 1975; 17: 1307–1312
   PubMed Web of Science ®Google Scholar
• Pearlmutter F. A., Szkrybalo M., Pettibone G. Specific arginine vasopressin binding in particulate membrane for rat aorta. Peptides 1985; 6: 426–431
   Google Scholar
• Litchfield J. T., Wilcoxon F. Simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949; 99–113
   PubMed Web of Science ®Google Scholar
• Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Murlas C., Madel A., Roberts J. M. The muscarinic cholinergic receptors of airway smooth muscle: Characterization by 3H QNB binding and contraction in vitro. J. Appl. Physiol. 1982; 52: 1084–109
   PubMedGoogle Scholar
• Sladek C. D., Blair M. L., Mangiapane M. Evidence against a pressor role for vasopressin in spontaneous hypertension. Hypertension 1987; 9(4)332–338
   PubMed Web of Science ®Google Scholar
• Rabito S. F., Carretero O. A., Scicli A. G. Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension. Hypertension 1981; 3: 34–38
   PubMed Web of Science ®Google Scholar
• Filep J., Frolich J. C., Fejes-Toth G. Evidence against a vasopressor role of ADH in malignant DOC-salt hypertension. Clin. Exper. Hypertension 1985; 7: 1457–1470
   Web of Science ®Google Scholar
• Mohring F., Mohring B., Petri M., Haack D. Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant 2-kidney Goldblatt hypertension. Circ. Res. 1978; 42: 17–22
   PubMed Web of Science ®Google Scholar
• Collis M. G. Vascular reactivity to vasopressin in doca-salt hypertensive rats. J. Pharm. Pharmacol. 1981; 33: 468–469
   PubMed Web of Science ®Google Scholar
• Rascher W., Lang R. E., Taubitz M., Meffle H., Unger T H., Ganten D., Gross F. Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex. Clin. Sci. 1981; 61: 153s–156s
   PubMed Web of Science ®Google Scholar
• Berecek K. H. Role of central vasopressin in cardiovascular regulation. J. Cardiovasc. Pharmacol. 1986; 8(Suppl 7)S76–S80
   PubMedGoogle Scholar
• Louis S T., Parent J. A., Lariviere R., Schiffrin E. L. Vasopressin responses and receptors in the mesenteric vasculature of estrogen-treated rats. Am. J. Physiol. 1986; 251: H885–H889
   PubMed Web of Science ®Google Scholar
• Nambi P., Whitman M., Stassen F. L., Crooke S. T. Vascular vasopressin receptors mediate inhibition of -adrenergic receptor induced cAMO accumulation. J. Pharmacol. Exp. Therap. 1986; 237(1)143–146
   PubMed Web of Science ®Google Scholar
• Bartlestone J. J., Nasmyth P. A. Vasopressin potentiation of catecholamines actions in dog, rat, cat, and aortic strip. Amer. J. Physiol. 1965; 208: 754–762
   PubMed Web of Science ®Google Scholar
• Iloeje E. I., Katovich M. J., Soltis E. E., Field F. P. Role of peripehral adrenergic responsiveness in the development of DOCA/NaCl hypertension in rats. Pharmaceur. Res. 1985; 6: 298–301
   Google Scholar
• Katovich M. J., Soltis E. E., Iloehe E., Field F. P. time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl treated rats. Pharmacol. 1984; 29: 173–180
   PubMed Web of Science ®Google Scholar
• Smith C. D., Katovich M. J. Effects of chronic nifedipine treatment on the development of DOCA/NaCl hypertension in rats. Federation Proc. 1986; 45: 300
   Google Scholar
• Woodcock E. A., Olsson C. A., Johnston C. I. Reduced vascular beta-adrenergic receptors in deoxycorticosterone salt hypertensive rats. Biochem Pharmacol. 1980; 29(11)1465–1468
   PubMed Web of Science ®Google Scholar
• Cohen M. L., Berkowitz B. A. Decreased vascular relaxation in hypertension. J. Pharmacol. Exp. Therap. 1976; 196(2)396–406
   PubMed Web of Science ®Google Scholar
• Schutz W., Sturer G., Tuisel E., Kraupp O. The cardiac and brain microvessel adenylate cyclase system in deoxycorticosterone acetate-hypertensive rat. J. Cardiovasc. Pharmacol. 1984; 6: 325
   PubMed Web of Science ®Google Scholar